News Sentiment

MGRX sentiment intelligence

Mangoceuticals, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 49 Balanced news tone 47 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 0.37 Week of 10 Jul 2026
Weighted tone 49/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

75/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-22.3% over one week, +2.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector

Market Reaction

Price moving ahead of tone

57/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 75/100 classification
One-week reaction -22.3% Price reacting lower
Trend fit Trend inactive 2.3% over four weeks
Fair value -91.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 31
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 10
Stock Titan 10
TradingKey 3
DirectorsTalk Interviews 2
TipRanks 2
Market source 2
www.marketscreener.com 1
Moomoo 1

Event Lens

What the news is about

Classified themes
Market update 20
Earnings 18
Guidance 3
Regulatory and legal 3
Deals and strategy 2
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-47 of 47
Stock Titan Direct company coverage

MGRX SEC Filings - Mangoceuticals, Inc. 10-K, 10-Q, 8-K Forms

This page on Stock Titan provides comprehensive access to Mangoceuticals, Inc. (MGRX) SEC filings, including annual reports (10-K), quarterly earnings (10-Q), and material events (8-K), along with insider trading forms. It details recent filings such as 8-K reports on stock place

Tone
Neutral 50/100
Event
Earnings
Published
30 Mar 2026 05:38
Source
Stock Titan
Meyka Direct company coverage

MGRX Mangoceuticals (NASDAQ) pre-market +99.81% Mar 24, 2026: watch heavy volume

Mangoceuticals (MGRX) stock saw a significant pre-market surge of nearly 100% on heavy volume, driven by a recent patent filing, a lawsuit announcement, and strong retail interest. Despite this price action, the company's fundamentals indicate negative EPS and weak operating cash

Tone
Neutral 50/100
Event
Regulatory and legal
Published
24 Mar 2026 09:10
Source
Meyka
MEXC Direct company coverage

Mangoceuticals (MGRX) Stock Rockets 130% Following CEO’s Substantial Share Award

Shares of Mangoceuticals (MGRX) surged over 129% after SEC filings revealed CEO Jacob Cohen received a 500,000-share bonus and transferred an additional 200,000 shares to The Tiger Cub Trust. This comes amid exploding trading volumes and significant company activity including lit

Tone
Positive 64/100
Event
Market update
Published
23 Mar 2026 22:38
Source
MEXC